Study reveals AI insights can predict development of disease a decade in advance
The study predicted the development of conditions including Alzheimer’s and heart disease
Read More
Tag: Alzheimer’s disease
MIT study reveals how specific cells in AD become vulnerable and resilient
The neurodegenerative condition is recognised as the most common form of dementia
Read More
Study suggests targeting amyloid beta production could be promising in AD
The neurodegenerative disease is currently the most common cause of dementia
Read More
Researchers reveal how a protein interaction can increase Alzheimer’s risk
AD is the most common form of dementia, which affects over 944,000 people in the UK
Read More
New study reveals how brain cell communication is linked to Alzheimer’s disease
Two support cells, microglia and astrocytes, were found to communicate with each other
Read More
LucyTx announces additional $12.5m research funding for neurological diseases
Alzheimer’s and Parkinson’s disease are responsible for more than 30 million cases globally
Read More
UCL study to assess link between navigation and AD using virtual reality
The progressive neurodegenerative condition is the most common form of dementia
Read More
Researchers suggest form of Alzheimer’s is transmissible via bone marrow transplants
The progressive neurodegenerative disease is estimated to affect 24 million people globally
Read More
Roche partners with Cardiff researchers to uncover new research into dementia
Affecting 55 million people globally, dementia impairs the ability to remember, think or make decisions
Read More
Poor spatial navigation could predict Alzheimer’s before symptom onset
Around 900,000 people in the UK are affected by the progressive neurodegenerative disease
Read More
Neurona secures $120m to advance lead cell therapy candidate for epilepsy
NRTX-1001 is being assessed for drug-resistant mesial temporal lobe epilepsy
Read More
Disrupted sleep could be associated with cognitive function changes
High amounts of disrupted sleep were found to affect memory and thinking performance
Read More
- Kahimmune Therapeutics enters licensing agreement with Gustave Roussy and SATT Paris-Saclay
- IBSA UK&I launches Perovial for the treatment of acute Peyronie’s disease
- En Carta Diagnostics’ EC Pocket Lyme test receives FDA Breakthrough Device Designation
- ALK’s EURneffy receives positive CHMP opinion for emergency anaphylaxis treatment in children
- CERo reports encouraging early data from phase 1 trial of CER‑1236
